(firstQuint)A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma.

 To determine the time to response, duration of response, and time to progression of patients treated with clofarabine.

 To determine the safety and tolerability of clofarabine in these patients.

.

 A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma@highlight

To determine the overall response rate (CR+PR) of patients with relapsed or refractory multiple myeloma treated with clofarabine.

